BIZTRAC BETA
COMPANY REGISTER PROFILE
990646066 ORG. NO. 2025 ACCOUNTS 10 SECTIONS
Active UPDATED 02.09.2026
Research and experimental development on natural sciences and engineering

NYKODE THERAPEUTICS ASA

Org. no. 990646066 Public limited company (ASA) Oslo Listed NYKD Incorporated 2006 Active
Ownership graph ↗
Revenue 2025 USD 453,000
Operating profit USD −29.2m
Equity USD 95.0m
Incorporated 2006
Employees 47
Share capital NOK 3.3m

Signals

2 flags
  • Driftsunderskudd 2025 Siste driftsresultat er negativt (−29,2 mill kr).
  • Nylig endring 2026-08-31 Aksjekapital registrert 2026-08-31.

NYKODE THERAPEUTICS ASA is registered as a public limited company in Oslo, Oslo with organisation number 990646066. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2006 and has 47 registered employees. Registered share capital is NOK 3.3m, divided into 326546444 shares. The company's stated purpose is: “Utvikling av biomedisinske produkter og tjenester. Formålet kan fremmes ved deltagelse i eller samarbeid med andre foretak i inn- og utland eller rådgivende virksomhet.”. The most recent filed accounts, for the 2025 financial year, show USD 453,000 in revenue and USD −29.2m in operating profit.

Former names: VACCIBODY AS, NYKODE THERAPEUTICS AS

This company reports in USD. The figures below are as filed, not converted to kroner. The top lists convert them to NOK at Norges Bank's rate for the end of the accounting year.

Key figures · 2025

Revenue
USD 453,000
▼ −95 %
Operating profit
USD −29.2m
▲ +36 %
Equity
USD 95.0m
▼ −32 %
Est. value
NOK 154.3m

Financial health · 2025

Liquidity
10.47
Very good
Current assets ÷ current liabilities
Profitability
-13.0%
Not satisfactory
Return on total assets
Solidity
92.5%
Very good
Equity as a share of total capital

Who owns NYKODE THERAPEUTICS ASA?

NYKODE THERAPEUTICS ASA has 20+ registered shareholders:

All shareholders and roles →

Frequently asked questions about NYKODE THERAPEUTICS ASA

Who owns NYKODE THERAPEUTICS ASA?

RASMUSSENGRUPPEN AS is the largest registered owner, with 9.2%.

What is the revenue of NYKODE THERAPEUTICS ASA?

NYKODE THERAPEUTICS ASA had revenue of USD 453,000 in 2025.

Who is the general manager of NYKODE THERAPEUTICS ASA?

Michael Thyrring Engsig is registered as general manager of NYKODE THERAPEUTICS ASA.

Where is NYKODE THERAPEUTICS ASA based?

NYKODE THERAPEUTICS ASA has its business address in Oslo.

Property

Business address Gaustadalléen 21, 0349 Oslo
Cadastral unit 301-42/127/0/0

292 companies are registered at this address.

The address this company is registered at, from the company register and matched against the cadastre. It does not say who owns the property — a company may be a tenant, and the address is often its accountant's. Source: Brønnøysundregistrene and © Kartverket.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.